Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Atreca Q3 EPS $(0.74) Down From $(0.66) YoY

Atreca (NASDAQ:BCEL) reported quarterly losses of $(0.74) per share. This is a 12.12 percent decrease over losses of $(0.66) per share from the same period last year.
byBenzinga Newsdesk
November 2, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Atreca (NASDAQ:BCEL) reported quarterly losses of $(0.74) per share. This is a 12.12 percent decrease over losses of $(0.66) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

‘Paxlovid, Nirmatrelvir 150mg And Ritonavir 100mg, Film-Coated Tablets Expiry Date Extended Beyond The Labelled Expiry Date On The Pack; Approved By The Medicines And Healthcare Products Regulatory Agency’ – U.K Government

By Benzinga Newsdesk
Today, 11:01 PM
https://www.gov.uk/government/publications/expiry-date-of-paxlovid-nirmatrelvir-and-ritonavir-antiviral-medication-extended/paxlovid-nirmatrelvir-150mg-and-ritonavir-100mg-film-coated-tablets-expiry-date-extended’ Paxlovid (nirmatrelvir 150mg and ritonavir 100mg) film-coated tablets expiry date extended Published 21 December 2022 This guidance…

PFE